Clinical TrialsSearch results
Number of results: 482
Recruiting
- A study on safety and efficacy of high-flow nasal cannula attachable hydrogen gas generator for ARDS
- Acute respiratory distress syndrome
- Nakao Atsunori
- 2022-04-12
Recruiting
- A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation
- Advanced/metastatic NSCLC with Exon 20 insertions and Uncommon/Single or Compound EGFR Mutations
- Wacheck Volker
- 2023-09-12
Recruiting
- A Study of Zipalertinib and Chemotherapy Compared With Chemotherapy Alone in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion
- Locally advanced or metastatic nonsquamous NSCLC harboring EGFR exon 20 insertion mutations
- Wacheck Volker
- 2023-09-12
Recruiting
- A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
- Locally Advanced, Unresectable, or Metastatic Non -Small Cell Lung Cancer
- Tsumura Akari
- 2021-09-28
Recruiting
- A study of dostarlimab in combination with carboplatin-paclitaxel in Japanese participants with primary advanced or recurrent endometrial cancer
- Endometrial Cancer
- Ishibashi Hideyasu
- 2024-03-28
Recruiting
- A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
- Breast Cancer
- Inoguchi Akihiro
- 2023-01-22
Recruiting
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Non-Small Cell Lung Cancer (NSCLC)
- Nakatani Iwami
- 2023-12-06
Recruiting
- A Randomized, Double-Blind, Phase III Study Comparing Investigational Drug HBI-8000 Combined With Nivolumab vs. Placebo with Nivolumab in Patients With Advanced Melanoma
- Unresectable or Metastatic Melanoma
- Ning John
- 2023-03-27
Recruiting
- A phase III, randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to first-line corticosteroids in primary immune thrombocytopenia
- Primary immune thrombocytopenia
- Yamauchi Kyosuke
- 2023-02-09
Recruiting
- A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Breast Cancer
- Inoguchi Akihiro
- 2024-02-21